| 85.09 -1.36 (-1.57%) | 02-20 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 101.63 |
1-year : | 106.21 |
| Resists | First : | 87.01 |
Second : | 90.94 |
| Pivot price | 85.26  |
|||
| Supports | First : | 80.67 |
Second : | 67.11 |
| MAs | MA(5) : | 86.29 |
MA(20) : | 84.91 |
| MA(100) : | 82.19 |
MA(250) : | 78.49 |
|
| MACD | MACD : | 0.9 |
Signal : | 1 |
| %K %D | K(14,3) : | 51.8 |
D(3) : | 55.5 |
| RSI | RSI(14): 51.3 |
|||
| 52-week | High : | 92.91 | Low : | 61.67 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ USPH ] has closed above bottom band by 47.5%. Bollinger Bands are 37.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 86.73 - 87.21 | 87.21 - 87.6 |
| Low: | 83.35 - 84.04 | 84.04 - 84.6 |
| Close: | 84.09 - 85.1 | 85.1 - 85.92 |
U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Fri, 20 Feb 2026
USPH: Barrington Research Maintains Outperform Rating with $103 Price Target | USPH Stock News - GuruFocus
Fri, 20 Feb 2026
U.S. Physical Therapy (NYSE:USPH) Earns "Outperform" Rating from Barrington Research - MarketBeat
Tue, 17 Feb 2026
U.S. Physical Therapy, Inc. (USPH) Stock Analysis: A 21% Upside Potential Beckons Investors - DirectorsTalk Interviews
Wed, 11 Feb 2026
U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended December 31, 2025 Earnings Release and Conference Call Dates - Business Wire
Sat, 07 Feb 2026
Is U.S. Physical Therapy (USPH) Pricing Offer An Opportunity After Recent Share Price Weakness - simplywall.st
Wed, 04 Feb 2026
U S Physical Therapy Inc Announces Strategic Alliance and Acquisition - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Care Facilities
|
|
| Shares Out | 15 (M) |
| Shares Float | 15 (M) |
| Held by Insiders | 1.9 (%) |
| Held by Institutions | 106.8 (%) |
| Shares Short | 908 (K) |
| Shares Short P.Month | 765 (K) |
| EPS | 2.42 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 33.11 |
| Profit Margin | 5.9 % |
| Operating Margin | 9.9 % |
| Return on Assets (ttm) | 4.2 % |
| Return on Equity (ttm) | 8.4 % |
| Qtrly Rev. Growth | 17.2 % |
| Gross Profit (p.s.) | 10.84 |
| Sales Per Share | 49.4 |
| EBITDA (p.s.) | 6.53 |
| Qtrly Earnings Growth | 23.6 % |
| Operating Cash Flow | 70 (M) |
| Levered Free Cash Flow | 35 (M) |
| PE Ratio | 35.16 |
| PEG Ratio | 0 |
| Price to Book value | 2.56 |
| Price to Sales | 1.72 |
| Price to Cash Flow | 18.6 |
| Dividend | 0.44 |
| Forward Dividend | 0 |
| Dividend Yield | 0.5% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|